Metraipolis › archive › dc_4697bb13d23b

The effect of BRAFV600E mutation on radioiodine therapy in patients with papillary thyroid carcinoma: a meta-analysis and systematic review — Europe PMC PMID:41064359

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41064359
DOI
10.3389/fendo.2025.1665545
License (as archived)
solo-consultazione
Archived
2026-11-09T19:34:34.957Z
SHA-256 of the archived text
10425d7fb06776ab1c4641e089013b812cf4ffb15180070ba7bfdc07bd72d88a
Stable URL of this page
https://metraipolis.com/documento/dc_4697bb13d23b

How to cite

The effect of BRAFV600E mutation on radioiodine therapy in patients with papillary thyroid carcinoma: a meta-analysis and systematic review — Europe PMC PMID:41064359 — Europe PMC (en), https://europepmc.org/article/MED/41064359 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4697bb13d23b (Metraipolis archive dc_4697bb13d23b, sha256 10425d7fb06776ab1c4641e089013b812cf4ffb15180070ba7bfdc07bd72d88a)
BibTeX
@misc{dc4697bb13d23b,
  title = {The effect of BRAFV600E mutation on radioiodine therapy in patients with papillary thyroid carcinoma: a meta-analysis and systematic review — Europe PMC PMID:41064359},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41064359},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4697bb13d23b; sha256 10425d7fb06776ab1c4641e089013b812cf4ffb15180070ba7bfdc07bd72d88a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41064359. Agents can read the archived copy with the MCP tool read_document.